Geode Capital Management, LLC Graybug Vision, Inc. Transaction History

Geode Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.46 - $1.05 $82 - $187	-179 Reduced 0.27%	66,214 $33,000
Q2 2022 Aug 12, 2022	BUY	$0.76 - $1.25 $6,646 - $10,932	8,746 Added 15.17%	66,393 $72,000
Q3 2021 Nov 12, 2021	SELL	$3.18 - $5.17 $40,497 - $65,839	-12,735 Reduced 18.09%	57,647 $191,000
Q2 2021 Aug 13, 2021	SELL	$3.53 - $6.1 $187,051 - $323,232	-52,989 Reduced 42.95%	70,382 $382,000
Q1 2021 May 12, 2021	BUY	$5.55 - $35.0 $66,222 - $417,620	11,932 Added 10.71%	123,371 $684,000
Q4 2020 Feb 12, 2021	BUY	$13.05 - $33.93 $1.45 Million - $3.78 Million	111,439 New	111,439 $3.23 Million

Ticker GRAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,517,700
Market Cap $63.5M
Description
Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the t...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.